 |
|
 Home |
 |
| Overview |
|
| Videos |
|
| Background |
|
| The Science |
|
| Contact Us |
|
| Replikins Press |
|
 |
|
|
The Science Figure 2, below, shows a similar correlation between the outbreaks of H5NI (bird Flu) between 1997 and the present and the Replikin Count™ peptide quantities during each of those years. Again the x axis indicates the year (note: there are two entries for 2005 (one for the first quarter and a second for the third quarter)) and the y axis indicates the Replikin Count™ peptide quantities (number of Replikins per 100 amino acids). The time periods for each epidemic of H5N1 are denoted in Figure 2 by E1, E2 and E3.  1 2 3 4 5 |
| Recent Press | |
Boston, November 27, 2009 - Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus... |
|
| New Non-Biological Synthetic Replikins™ Vaccines Shown to Be Effective and Fast; WorldVaccines™, Ltd. Formed for Testing and Distribution Old Biological Vaccines for Emergent Diseases - Too Little, Too Late
Boston, October 19, 2009 - There is increasing evidence that, with best intent, current biological technology cannot supply the world's six billion humans, and animal populations, with vaccines against emerging diseases at a rate that can contend with a disease's rapid appearance and change... |
|
Copyright © 2010 Replikins Ltd. All rights reserved.